Stroke RSS

Filtered By:
Source: Journal of Hypertension
Drug: Omnipaque

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes
Conclusion: Dapagliflozin seemingly influences systemic and renal hemodynamics independently and beyond glucose lowering in people with type 2 diabetes. This clinical trial was registered at https://clinicalTrials.gov (ID: NCT02682563).
Source: Journal of Hypertension - August 13, 2020 Category: Cardiology Tags: ORIGINAL PAPERS: Treatment Source Type: research